| 12247031 |
Cyclobutyl pyrazolopyrimidine PDE9 inhibitors |
Jason M. Cox, John S. Debenham, Zhuyan Guo, Zhong Lai, Dongfang Meng |
2025-03-11 |
|
| 12195445 |
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors |
Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey, Harry R. Chobanian +11 more |
2025-01-14 |
|
| 11802122 |
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors |
Ian M. Bell, Christopher James Bungard, Christopher S. Burgey, Jason M. Cox, Michael J. Kelly, III +7 more |
2023-10-31 |
$669,245,000 |
| 11377438 |
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors |
Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey, Harry R. Chobanian +11 more |
2022-07-05 |
$309,260,000 |
| 11028092 |
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors |
Jason M. Cox, John S. Debenham, Zahid Hussain, Derun Li, Dongfang Meng +1 more |
2021-06-08 |
$110,875,000 |
| 10934294 |
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors |
Jason M. Cox, John S. Debenham, Zhuyan Guo, Jiafang He, Zahid Hussain +5 more |
2021-03-02 |
$166,587,000 |
| 10806724 |
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use |
Iyassu Sebhat, Scott B. Hoyt, Robert R. Wilkening, Duane DeMong |
2020-10-20 |
$384,239,000 |
| 10335399 |
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use |
Iyassu Sebhat, Scott B. Hoyt, Robert R. Wilkening, Duane DeMong |
2019-07-02 |
$172,432,000 |
| 10072003 |
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use |
Christopher James Bungard, Jessica Frie, Yongxin Han, Scott B. Hoyt, Peter J. Manley +5 more |
2018-09-11 |
$76,678,000 |
| 9868733 |
Azabenzimidazole tetrahydrofuran derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Jacqueline D. Hicks +8 more |
2018-01-16 |
$61,578,000 |
| 9650375 |
Indole derivatives useful as anti-diabetic agents |
John J. Acton, III, Rajan Anand, Qun Dang, Iyassu Sebhat, Zhifa Pu +1 more |
2017-05-16 |
$88,840,000 |
| 9556193 |
Benzimidazole hexahydrofuro[3,2-b]furan derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Erin N. Guidry +9 more |
2017-01-31 |
|
| 9433621 |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
F. George Njoroge, Cecil D. Kwong, Subramaniam Ananthan, Frank Bennett, Francisco Velazquez +15 more |
2016-09-06 |
$101,652,000 |
| 9416154 |
5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
Vishal Verma, F. George Njoroge, Vinay M. Girijavallabhan, Stephane L. Bogen, Qun Dang +1 more |
2016-08-16 |
$77,022,000 |
| 9408863 |
5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases |
Vishal Verma, F. George Njoroge, Kevin X. Chen |
2016-08-09 |
$96,538,000 |
| 9290517 |
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives |
James M. Apgar, Tesfaye Biftu, Ping Chen, Danqing Feng, Erin N. Guidry +10 more |
2016-03-22 |
$71,894,000 |
| 9156872 |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
Vinay M. Girijavallabhan, F. George Njoroge, Stephane L. Bogen, Frank Bennett, Vishal Verma +10 more |
2015-10-13 |
$72,216,000 |
| 9061041 |
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
Vinay M. Girijavallabhan, F. George Njoroge, Stephane L. Bogen, Vishal Verma, Frank Bennett +7 more |
2015-06-23 |
$67,157,000 |
| 8697694 |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
F. George Njoroge, Cecil D. Kwong, Subramaniam Ananthan, Frank Bennett, Jeremy Clark +15 more |
2014-04-15 |
$71,592,000 |
| 8680294 |
Enantio- and stereo specific synthesis of β-amino-α-hydroxy amides |
John F. Traverse, William M. Leong, Steven P. Miller, Jennifer Albaneze-Walker, Thomas J. Hunter +15 more |
2014-03-25 |
$100,762,000 |
| 8541434 |
Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
Cecil D. Kwong, F. George Njoroge, Subramaniam Ananthan, Frank Bennett, Jeremy Clark +9 more |
2013-09-24 |
$64,515,000 |
| RE43298 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus |
Anil K. Saksena, Viyyoor M. Girijavallabhan, Raymond G. Lovey, Edwin Jao, Frank Bennett +22 more |
2012-04-03 |
|
| 8067379 |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
Frank Bennett, Raymond G. Lovey, Yuhua Huang, Siska Hendrata, Anil K. Saksena +9 more |
2011-11-29 |
|
| 7816326 |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
Francisco Velazquez, Stephane L. Bogen, Srikanth Venkatraman, F. George Njoroge, Neng-Yang Shih |
2010-10-19 |
|
| 7759499 |
Compounds as inhibitors of hepatitis C virus NS3 serine protease |
Srikanth Venkatraman, F. George Njoroge, Melissa Blackman, Wanil Wu, Latha G. Nair +5 more |
2010-07-20 |
|
